Cynthia Chmielewski is a multiple myeloma hero for many around the world.
Welireg outperformed Afinitor in time to disease progression and patient-reported quality of life in the treatment of metastatic clear cell renal cell carcinoma.
Fear of facing discriminatory behavior within the health care system, along with other factors, may keep members of the LGBTQIA+ community from receiving cancer diagnoses.
A patient details the compassionate support that she received from an oncology nurse while receiving back-to-back treatments for cancer.
A man describes his wife’s tireless efforts to advocate for people of color in the metastatic breast cancer field, where many still face disparities within care, inclusion in clinical trials and survival outcomes.
When experiencing loss, always look forward and have hope.
A woman dedicates a poem to the experience of meeting a fellow breast cancer survivor.
Upal Basu Roy has a true gift of being able to think from his heart. He educates the patient community, helps patients navigate the fragmented system, fights for drug access issues in other countries, addresses disparities and supports patient-driven initiatives in research and advocacy.
Although she has always been driven to excel, Karen Driskill's, M.S., RN, purpose became more focused after her mother-in-law passed away from intrahepatic cholangiocarcinoma in 2010.
From her earliest childhood days, Tammy Allred, RN, OCN, had a vision for her future: to soothe and to heal.
The HIF-2a Inhibitor induced clinical responses among patients with von Hippel-Lindau disease–associated kidney cancer, according to results presented at the 2020 ASCO Virtual Scientific Program.
While the summer months are the perfect time for outdoor activities with friends and family, it is crucial to protect yourself from skin cancer.
Looking back in 2018, I am so glad that we sought out the other opinions. Nerve wracking as it was, the process opened up other options we would not have known about.
Here are four signs of your doctor not listening and four things I do when they don't listen to me.
Lori A. Leslie, MD, and Hoshiyuki Iida, APN, offer closing thoughts on the future treatment landscape of chronic lymphocytic leukemia.
Noelle Paul has time to talk on the way home from her job as an oncology surgical nurse at Memorial Sloan Kettering Cancer Center in New York City.
An Extraordinary Healer article honoring LAUREN H. McMURRY, B.S.N., RN [ST. JUDE CHILDREN’S RESEARCH HOSPITAL, MEMPHIS, TENNESSEE]
Elizabeth Swisher, M.D., professor, Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Breast and Ovarian Cancer Prevention Program, Seattle Cancer Care Alliance, discusses the side effects of rucaparib in the ARIEL2 trial, for patients with relapsed, platinum-sensitive high-grade ovarian carcinoma.
C. Ola Landgren provides an overview of the diagnosis and treatment of smoldering multiple myeloma.
Specialized hospital programs — with help from "The Who" rockers — support teens and young adults through cancer.
"Her goal is to improve the cancer experience and management of cancer as a chronic disease, extending those efforts into survivorship."
A partnership between the Pancreatic Cancer Action Network and Perthera, a self-described "concierge" for molecular diagnostic testing, is giving patients with this hard-to-treat cancer the ability to determine the best course of treatment.
Before closing out their discussion on differentiated thyroid cancer, patients and health care professionals alike consider unmet needs in this space.
Obesity may increase the risk of cancer recurrence. Here's what you can do to counteract it.
An Extraordinary Healer essay honoring PAM LOWRY, RN, B.S.N., CEN, OCN [MOFFITT CANCER INSTITUTE, TAMPA, FLORIDA]